SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-016885
Filing Date
2024-01-26
Accepted
2024-01-26 17:26:57
Documents
14
Period of Report
2024-01-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d650325d8k.htm   iXBRL 8-K 33690
6 GRAPHIC g650325g0127021605271.jpg GRAPHIC 4150
  Complete submission text file 0001193125-24-016885.txt   204485

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA evlo-20240126.xsd EX-101.SCH 3209
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evlo-20240126_def.xml EX-101.DEF 14171
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE evlo-20240126_lab.xml EX-101.LAB 24845
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evlo-20240126_pre.xml EX-101.PRE 15047
8 EXTRACTED XBRL INSTANCE DOCUMENT d650325d8k_htm.xml XML 5155
Mailing Address 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035
Business Address 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38473 | Film No.: 24569259
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)